Impact Biomedical IBO
NYSE IBO
$4.02 +0.22 (+5.78%)
As of: Oct 23, 2026 · 1:02 PM EDT

Impact Biomedical (IBO) Share-based Compensation (2024 - 2026)

Updated

Impact Biomedical's Share-based Compensation was $1.44 million in Q1 2026, compared with $29,000 a year earlier.

Analysis

Impact Biomedical (IBO) Share-based Compensation (2024 - 2026) Analysis & Trends

For FY2025, Share-based Compensation at Impact Biomedical came in at $190,000, up 900.0% from FY2024.

  • In earlier years, Share-based Compensation was $19,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,138.00 Bn 1,106.58 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 634.40 Bn 554.26 Bn 17.30 Bn 357.00 Mn
3 AbbVie 506.36 Bn 479.47 Bn 12.70 Bn 166.00 Mn
4 Merck 358.30 Bn 312.68 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 293.12 Bn 257.11 Bn 11.24 Bn -
6 Astrazeneca 265.36 Bn 239.05 Bn 12.86 Bn -
7 Amgen 238.40 Bn 193.80 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 195.15 Bn 169.35 Bn 6.22 Bn 231.00 Mn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn 249.00 Mn
10 Impact Biomedical 433.42 Mn 433.37 Mn 2,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.44 Mn
Jun 30, 2025 2,000.00
Mar 31, 2025 29,000.00
Dec 31, 2024 19,000.00
API Access

Impact Biomedical Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IBO&period=max&api_key=YOUR_API_KEY